Xencor, Inc. - Common Stock (NQ:XNCR)

14.16 -0.03 (-0.21%)

Streaming Delayed Price Updated: 10:08 AM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Volume	64,880
Open	14.22
Bid (Size)	14.06 (300)
Ask (Size)	14.17 (200)
Prev. Close	14.19
Today's Range	14.01 - 14.49
52wk Range	6.920 - 23.84
Shares Outstanding	59,924,016
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones

January 08, 2026

From Xencor, Inc.

Via Business Wire

Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies

December 09, 2025

From Xencor, Inc.

Via Business Wire

Performance

YTD	-5.1%	-5.1%
1 Month	-15.8%	-15.8%
3 Month	+8.4%	+8.4%
6 Month	+52.6%	+52.6%
1 Year	-39.6%	-39.6%

More News

Xencor to Participate at Upcoming Investor Conferences

November 10, 2025

From Xencor, Inc.

Via Business Wire

Xencor Reports Third Quarter 2025 Financial Results

November 05, 2025

From Xencor, Inc.

Via Business Wire

Beyond The Numbers: 4 Analysts Discuss Xencor Stock ↗

September 02, 2025

Via Benzinga

Critical Insights From Xencor Analyst Ratings: What You Need To Know ↗

December 02, 2024

Via Benzinga

Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma

October 24, 2025

From Xencor, Inc.

Via Business Wire

Xencor to Host Webcast and Conference Call to Discuss Initial Results from the Ongoing Phase 1 Dose-Escalation Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma

October 21, 2025

From Xencor, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 14, 2025

Via Benzinga

Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 14, 2025

From Xencor, Inc.

Via Business Wire

Xencor to Participate at Upcoming Investor Conferences

August 27, 2025

From Xencor, Inc.

Via Business Wire

Xencor (XNCR) Q2 Revenue Jumps 82% ↗

August 06, 2025

Via The Motley Fool

Xencor Reports Second Quarter 2025 Financial Results

August 06, 2025

From Xencor, Inc.

Via Business Wire

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors

July 31, 2025

From Xencor, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 09, 2025

Via Benzinga

Xencor Reports First Quarter 2025 Financial Results

May 07, 2025

From Xencor, Inc.

Via Business Wire

Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease

April 29, 2025

From Xencor, Inc.

Via Business Wire

Xencor Appoints Todd Simpson to Board of Directors

March 13, 2025

From Xencor, Inc.

Via Business Wire

Xencor Reports Fourth Quarter and Full Year 2024 Financial Results

February 27, 2025

From Xencor, Inc.

Via Business Wire

Eliminating Some Screened Stocks ↗

February 09, 2025

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 05, 2025

Via Benzinga

Xencor to Participate at Upcoming Investor Conferences

November 26, 2024

From Xencor, Inc.

Via Business Wire

Xencor Reports Third Quarter 2024 Financial Results

November 06, 2024

From Xencor, Inc.

Via Business Wire

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease

November 04, 2024

From Xencor, Inc.

Via Business Wire

Frequently Asked Questions

Is Xencor, Inc. - Common Stock publicly traded?

Yes, Xencor, Inc. - Common Stock is publicly traded.

What exchange does Xencor, Inc. - Common Stock trade on?

Xencor, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Xencor, Inc. - Common Stock?

The ticker symbol for Xencor, Inc. - Common Stock is XNCR on the Nasdaq Stock Market

What is the current price of Xencor, Inc. - Common Stock?

The current price of Xencor, Inc. - Common Stock is 14.16

When was Xencor, Inc. - Common Stock last traded?

The last trade of Xencor, Inc. - Common Stock was at 01/09/26 10:08 AM ET

What is the market capitalization of Xencor, Inc. - Common Stock?

The market capitalization of Xencor, Inc. - Common Stock is 848.52M

How many shares of Xencor, Inc. - Common Stock are outstanding?

Xencor, Inc. - Common Stock has 849M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.